Novo CEO pressed by Senate to chop prices of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen told lawmakers the corporation would contemplate new talks with insurers about the checklist prices of Wegovy and copyright when they pledge to keep the medicines on their own formularies. This system aligns with https://labelthefigurewiththeitem16050.affiliatblogger.com/82792287/considerations-to-know-about-healthcare-news